CCA
MED icon

Conestoga Capital Advisors’s Medifast MED Stock Holding History

Conestoga Capital Advisors’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-506,793
Closed -$15.4M – 122
2014
Q2 		$15.4M Buy
506,793
+28,730
+6% +$895K 1.03% 42
2014
Q1 		$13.9M Buy
478,063
+114,893
+32% +$3.08M 0.88% 46
2013
Q4 		$9.49M Buy
363,170
+29,231
+9% +$749K 0.64% 47
2013
Q3 		$8.98M Buy
333,939
+1,545
+0.5% +$41.3K 0.77% 47
2013
Q2 		$8.56M Buy
+332,394
New +$8.73M 0.88% 44

Other funds holding MED

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
GGPE
Golden Gate Private Equity San Francisco, California $241M AUM 13.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Conestoga Capital Advisors's MED Position: Q3 2014 in Review

Conestoga Capital Advisors sold out of Medifast (MED) in Q3 2014, closing a stake of 506,793 shares — an estimated $15.4M sold.

Conestoga Capital Advisors first reported a position in MED in Q2 2013 and held it in 5 quarters. The position peaked at $15.4M in Q2 2014. 124 funds tracked by Wall St. Rank hold MED as of Q3 2014.

  • Conestoga Capital Advisors reported no remaining Medifast position as of Q3 2014 after selling out during the quarter.
  • Conestoga Capital Advisors sold 506,793 Medifast shares in Q3 2014, an estimated $15.4M.
  • Conestoga Capital Advisors first reported a position in Medifast in Q2 2013 and held it in 5 quarters.
  • Conestoga Capital Advisors's Medifast position peaked at $15.4M in Q2 2014.
  • 124 funds tracked by Wall St. Rank held Medifast as of Q3 2014.

Based on Conestoga Capital Advisors's 13F filing for Q3 2014, filed 7 Nov 2014.